BeOne Medicines Ltd. American Depositary Shares
Symbol: ONC (NASDAQ)
0.00
▼ (-100.00%) -340.700
Company Description:
Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeOne runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeOne's revenue.
Key Stats
- Today's Open: $0
- Today's High: $0
- Today's Low: $0
- Today's Volume: 0
- Yesterday Close: $340.7
- Yesterday High: $342.26
- Yesterday Low: $335.57
- Yesterday Volume: 273.72K
- Last Min Volume: 0
- Last Min High: $0
- Last Min Low: $0
- Last Min VWAP: $0
Company Profile
- Name: BeOne Medicines Ltd. American Depositary Shares
- Website: https://www.beonemedicines.com
- Listed Date: 2016-02-03
- Location: BASEL,
- Market Status: Active
- CIK Number: 0001651308
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $37.42B
- Round Lot: 100
- Outstanding Shares: 109.84M
- Asset Type: ADRC
RECENT FILINGS FOR ONC
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-18 | 4 | View |
| 2025-09-16 | 144 | View |
| 2025-09-16 | 144 | View |
| 2025-09-12 | 4 | View |
| 2025-09-11 | 4 | View |
| 2025-09-11 | 4 | View |
| 2025-09-10 | 144 | View |
| 2025-09-09 | 4 | View |
| 2025-09-09 | 144 | View |
| 2025-09-05 | 144 | View |
| 2025-09-04 | 4 | View |
| 2025-09-02 | 144 | View |
| 2025-08-29 | 8-K | View |
| 2025-08-25 | 8-K | View |
| 2025-08-15 | 4 | View |
| 2025-08-15 | 4 | View |
| 2025-08-13 | 144 | View |
| 2025-08-13 | 144 | View |
| 2025-08-06 | 10-Q | View |
| 2025-08-06 | 8-K | View |
Latest News on ONC